Clinical Trials · 22. March 2024

This blog post examines key takeaways from the February 2024 CTAG meeting for Regulatory Affairs and Study Start-Up professionals. The focus is on proposed changes to streamline applications for substantial modifications and adding new EU member states to trials. Additionally, the post explores resources to aid sponsors transitioning from the Clinical Trials Directive to the CTR.